Israeli Pharmaceutical Company Oramed Raises $5.6M
By Anouk Lorie December 13, 2012 < 1 minute
Oramed, and Israeli company which is developing an innovative oral insulin capsule, has announced that it has raised $5.6 million in a private placement. The funds will be used to finance clinical trials of the capsule.
Subscribe to NoCamels weekly newsletter and get our top stories
AI Made In Israel Helping Europeans Conceive Via IVF
June 08, 2023